Target intelligence / Profile preview

GDP dissociation inhibitor 2 pseudogene 2 (GDI2P2)

Target: GDI2P2
Molecular classification: Other (pseudogene)

Overview

GDP dissociation inhibitor 2 pseudogene 2 (GDI2P2) is a **pseudogene** corresponding to the gene encoding GDP dissociation inhibitor 2 (GDI2) in humans[1][3]. Unlike the functional GDI2 gene, which encodes a protein that regulates the activity of rab family GTPases involved in vesicular trafficking, GDI2P2 does **not** encode a protein and has no known biological function, role in disease, or therapeutic relevance. As a pseudogene, it is not considered a pharmacological target, and there is no evidence for direct involvement in biological processes, disease, or drug interaction[1][3].

Other names: GDI2P2GDP dissociation inhibitor 2 pseudogene 2

Beyond the preview

Go deeper on GDP dissociation inhibitor 2 pseudogene 2 (GDI2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GDP dissociation inhibitor 2 pseudogene 2 (GDI2P2).

Explore the full profile